Description
Recombinant monoclonal antibody to CD16. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma YFC 120.5.
Target
CD16
Target Alias Names
FcgRIIa, CD16, Low affinity immunoglobulin gamma Fc region receptor III-A, CD16a antigen, Fc-gamma RIII-alpha, Fc-gamma RIII, Fc-gamma RIIIa, FcRIII, FcRIIIa, FcR-10, IgG Fc receptor III-2, FCGR3A, CD16A, FCG3, FCGR3, IGFR3, Fc-gamma receptor IIIb, YFC120
Isotype/Mimetic
IgG2b
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression